Insight-As-A-Service (IAAS)
One integrated AI layer for Oncology, Immunology, and Cardiology that identifies, salvages, and recruits for your most critical assets.
This Platform utilizes four interconnected pillars covering the entire drug lifecycle, with a core focus on Oncology, Immunology, and Cardiology:
Identifies new indications (repurposing), novel combinations, or next-generation molecule opportunities for shelved or existing assets by scanning biological and clinical data.
A clinical trial intelligence platform that matches eligible patients to relevant studies by analyzing clinical, genomic, and real-world data, helping accelerate recruitment and improve trial participation.
A clinical intelligence platform that unifies fragmented patient data to deliver a comprehensive longitudinal view, enabling AI-assisted care planning, patient stratification, and coordinated patient care.
We deliver measurable outcomes across the clinical development continuum, transforming R&D sunk costs into market leadership.
Identify responder sub-populations in failed trials using TrialFit®.
Generate AI-assisted care plans using Patient Panorama®.
Rank generic/biosimilar candidates via DrugSuccess.Ai™.
From research to patient care, our AI-powered insights help organizations achieve faster decisions, better outcomes, and greater operational efficiency.
Our computational biologists and oncologists will deliver a “Proof of Insight” dossier for your top asset.
We send really
good emails.
Subscribe to our newsletter to receive the latest updates on products, sustainability efforts and services.